The role of inflammation in irritable bowel syndrome (IBS)

References

• DrossmanDAFunctional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IVGastroenterology2016150612621279
   Web of Science ®Google Scholar
• LovellRMFordACGlobal prevalence of and risk factors for irritable bowel syndrome: a meta-analysisClin Gastroenterol Hepatol201210771272122426087
   PubMed Web of Science ®Google Scholar
• AkehurstRLBrazierJEMathersNHealth-related quality of life and cost impact of irritable bowel syndrome in a UK primary care settingPharmacoeconomics200220745546212093301
   PubMed Web of Science ®Google Scholar
• KimJHLinEPimentelMBiomarkers of Irritable Bowel SyndromeJ Neurogastroenterol Motil2017231202627817184
   PubMed Web of Science ®Google Scholar
• BarbaraGCremonCde GiorgioRMechanisms underlying visceral hypersensitivity in irritable bowel syndromeCurr Gastroenterol Rep201113430831521537962
   PubMedGoogle Scholar
• BercikPVerduEFCollinsSMIs irritable bowel syndrome a low-grade inflammatory bowel disease?Gastroenterol Clin North Am200534223524515862932
   PubMed Web of Science ®Google Scholar
• KirschRKirschRHRiddellRHRiddellRHistopathological alterations in irritable bowel syndromeMod Pathol200619121638164517013373
   PubMed Web of Science ®Google Scholar
• CastroGAGut immunophysiology: Regulatory pathways within a common mucosal immune systemPhysiology1989425964
   Google Scholar
• SalzmannJLPeltier-KochFBlochFPetiteJPCamilleriJPMorphometric study of colonic biopsies: a new method of estimating inflammatory diseasesLaboratory investigation; a journal of technical methods and pathology19896068478512733385
   PubMed Web of Science ®Google Scholar
• CremonCStanghelliniVBarbaroMRRandomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndromeAliment Pharmacol Ther201745790992228164346
   PubMed Web of Science ®Google Scholar
• O’SullivanClaytonNBreslinNPIncreased mast cells in the irritable bowel syndromeNeurogastroenterology and Motility200012544945711012945
   PubMed Web of Science ®Google Scholar
• KlookerTKBraakBKoopmanKEThe mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndromeGut201059912131221 Jan 1:gut-201020650926
   PubMed Web of Science ®Google Scholar
• TörnblomHLindbergGNybergBVeressBFull-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndromeGastroenterology200212361972197912454854
   PubMed Web of Science ®Google Scholar
• ÖhmanLIsakssonSLindmarkA-CT-Cell Activation in Patients With Irritable Bowel SyndromeAm J Gastroenterol200910451205121219367268
   PubMed Web of Science ®Google Scholar
• FoleySGarsedKSinghGImpaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activationGastroenterology201114051434144321315720
   PubMed Web of Science ®Google Scholar
• ÖhmanLIsakssonSLundgrenASimrénMSjövallHA Controlled Study of Colonic Immune Activity and β7 Blood T Lymphocytes in Patients With Irritable Bowel SyndromeClinical Gastroenterology and Hepatology200531098098616234043
   PubMed Web of Science ®Google Scholar
• ThabaneMKottachchiDTMarshallJKSystematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndromeAliment Pharmacol Ther200726453554417661757
   PubMed Web of Science ®Google Scholar
• MearinFPérez-OliverasMPerellóADyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort studyGastroenterology200512919810416012939
   PubMed Web of Science ®Google Scholar
• MarshallJKThabaneMBorgaonkarMRJamesCPostinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogenClinical Gastroenterology and Hepatology20075445746017289440
   PubMed Web of Science ®Google Scholar
• GweeKACollinsSMReadNWIncreased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndromeGut200352452352612631663
   PubMed Web of Science ®Google Scholar
• SpillerRCJenkinsDThornleyJPIncreased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndromeGut200047680481111076879
   PubMed Web of Science ®Google Scholar
• SundinJRangelIFuentesSAltered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distressAliment Pharmacol Ther201541434235125521822
   PubMed Web of Science ®Google Scholar
• Jalanka-TuovinenJSalojärviJSalonenAFaecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndromeGut2014631117374524310267
   PubMed Web of Science ®Google Scholar
• SundinJRangelIRepsilberDBrummerR-JCytokine response after stimulation with key commensal bacteria differ in post-infectious irritable bowel syndrome (PI-IBS) patients compared to healthy controlsPLoS One2015109e013483626366730
   PubMed Web of Science ®Google Scholar
• KajanderKMyllyluomaERajilić-StojanovićMClinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiotaAliment Pharmacol Ther2008271485717919270
   PubMed Web of Science ®Google Scholar
• AlanderMSatokariRKorpelaRPersistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosusGG, after oral consumptionApplied and Environmental Microbiology19996513513549872808
   PubMed Web of Science ®Google Scholar
• NgQXHoCYXShinDA meta-analysis of the use of rifaximin to prevent travellers’ diarrhoeaJ Travel Med201724515
   Web of Science ®Google Scholar
• ZhangBZhangHDuCMetabolic responses of the growing Daphnia similis to chronic AgNPs exposure as revealed by GC-Q-TOF/MS and LC-Q-TOF/MSWater Res201711413514328237781
   PubMed Web of Science ®Google Scholar
• HalpinSJFordACPrevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysisAm J Gastroenterol2012107101474148222929759
   PubMed Web of Science ®Google Scholar
• GracieDJWilliamsCJMSoodRNegative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome–type Symptoms in Patients With Inflammatory Bowel DiseaseClinical Gastroenterology and Hepatology201715337638427189912
   PubMed Web of Science ®Google Scholar
• Vivinus-NébotMFrin-MathyGBziouecheHFunctional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammationGut201463574475223878165
   PubMed Web of Science ®Google Scholar
• NgQXSohAYSLimDYYeoWSAgomelatine, a novel therapeutic option for the management of irritable bowel syndromeJ Clin Pharm Ther201843575275630014556
   PubMed Web of Science ®Google Scholar
• NgQXSohAYSLokeWSystematic review with meta-analysis: The association between post-traumatic stress disorder and irritable bowel syndromeJ Gastroenterol Hepatol Epub2582018
   Web of Science ®Google Scholar
• PaceTWWMletzkoTCAlagbeOIncreased stress-induced inflammatory responses in male patients with major depression and increased early life stressAm J Psychiatry200616391630163316946190
   PubMed Web of Science ®Google Scholar
• WoutersMMVan WanrooySNguyenAPsychological comorbidity increases the risk for postinfectious IBS partly by enhanced susceptibility to develop infectious gastroenteritisGut2016651279128826071133
   PubMed Web of Science ®Google Scholar
• BritesDFernandesANeuroinflammation and depression: microglia activation, extracellular microvesicles and microRNA dysregulationFront Cell Neurosci2015947626733805
   PubMed Web of Science ®Google Scholar
• DinanTGCryanJShanahanFKeelingPWNQuigleyEMMIBS: an epigenetic perspectiveNat Rev Gastroenterol Hepatol20107846547120585338
   PubMed Web of Science ®Google Scholar
• NgQXYongBZJHoCYXEarly life sexual abuse is associated with increased suicide attempts: An update meta-analysisJ Psychiatr Res20189912914129454220
   PubMed Web of Science ®Google Scholar
• ClarkeGQuigleyEMMCryanJFDinanTGIrritable bowel syndrome: towards biomarker identificationTrends Mol Med2009151047848919811951
   PubMed Web of Science ®Google Scholar
• ClarkeGFitzgeraldPCryanJFCassidyEMQuigleyEMDinanTGTryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohortBMC Gastroenterol200991619154614
   PubMed Web of Science ®Google Scholar
• ChangLSundareshSElliottJDysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndromeNeurogastroenterology & Motility200921214915918684212
   PubMed Web of Science ®Google Scholar
• GroverMCamilleriMEffects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseasesJ Gastroenterol201348217718123254779
   PubMed Web of Science ®Google Scholar
• HallGbcKamathMvCollinsSHeightened central affective response to visceral sensations of pain and discomfort in IBSNeurogastroenterology & Motility2010223276e8020003075
   PubMed Web of Science ®Google Scholar
• ElsenbruchSRosenbergerCSchedlowskiMForstingMGizewskiERAffective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI studyPPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie20095902
   Google Scholar